ROS1 rearrangements define a unique molecular class of lung cancers.

By K. Bergethon, A. Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine Lovly, Nerina T. McDonald, P. Massion, C. Siwak-Tapp, Adriana L. Gonzalez, Rong Fang and 12 more. Journal of Clinical Oncology, 2012

728 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/8c4ea778aea2922b53a3c81622f096f48a055347

Citations in the corpus

• Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. (2013, neutral): “Could not be evaluated† 17 (10) 17 (10)”